Health Care & Life Sciences » Pharmaceuticals | Impax Laboratories Inc.

Impax Laboratories Inc. | Balance Sheet

Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
Cash & Short Term Investments
413
415
340
180
182
Total Accounts Receivable
113
146
324
257
302
Inventories
70
81
126
175
158
Other Current Assets
64
89
32
18
53
Total Current Assets
660
730
822
631
696
Net Property, Plant & Equipment
188
188
214
233
125
Intangible Assets
57
54
812
828
470
Other Assets
58
64
74
61
61
Total Assets
1,000
1,080
1,922
1,823
1,351
ST Debt & Current Portion LT Debt
-
-
-
18
18
Accounts Payable
27
32
56
59
81
Income Tax Payable
-
21
1
-
-
Other Current Liabilities
106
127
270
245
255
Total Current Liabilities
154
159
327
321
354
Long-Term Debt
-
-
425
814
770
Provision for Risks & Charges
-
26
-
-
-
Deferred Taxes
34
42
72
70
3
Other Liabilities
33
7
36
64
37
Total Liabilities
189
192
860
1,199
1,164
Common Equity (Total)
810
888
1,062
624
187
Total Shareholders' Equity
810
888
1,062
624
187
Total Equity
810
888
1,062
624
187
Liabilities & Shareholders' Equity
1,000
1,080
1,922
1,823
1,351

About Impax Laboratories

View Profile
Address
400 Crossing Boulevard
Bridgewater New Jersey 08807
United States
Employees -
Website http://www.amneal.com
Updated 09/14/2018